Apyx Medical (APYX) Cost of Revenue (2011 - 2026)

Apyx Medical's Cost of Revenue history runs 16 years deep, the most recent figure standing at $4.6 million for Q1 2026.

• Quarterly Cost of Revenue rose 21.25% year-over-year to $4.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $20.6 million (up 13.11% YoY) and the FY2025 annual result came in at $19.8 million, up 5.65% from the prior year.
• Cost of Revenue was $4.6 million for Q1 2026 at Apyx Medical, down from $7.2 million in the prior quarter.
• Across five years, Cost of Revenue topped out at $7.2 million in Q4 2025 and bottomed at $3.4 million in Q3 2022.
• A 5-year average of $4.5 million and a median of $4.4 million in 2022 frame the typical range for Cost of Revenue.
• Annual changes were most pronounced in 2022 — Cost of Revenue surged 53.85% — and 2025, when it dropped 12.34%.
• Apyx Medical's Cost of Revenue stood at $4.4 million in 2022, then jumped by 31.19% to $5.7 million in 2023, then slipped by 8.29% to $5.3 million in 2024, then soared by 36.27% to $7.2 million in 2025, then plunged by 36.29% to $4.6 million in 2026.
• Business Quant data shows APYX's Cost of Revenue at $4.6 million in Q1 2026, $7.2 million in Q4 2025, and $4.6 million in Q3 2025.